THE DEAL, AT A GLANCE
From the announcementFormation Bio
01Who is involvedBacked by a16z, with participation from Sanofi and other investorsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedFormation Bio raised $372M Series DFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersFormation Bio's $372 million Series D gives the company capital to expand its drug pipeline and AI-driven drug development platform in Digital Health.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Formation Bio · Financing Record
Explore source-linked visual explanations for Formation Bio. Unsupported claims are withheld while source review continues.
Record 2119 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →